135 related articles for article (PubMed ID: 4075255)
1. In vitro evaluation of a toxic metabolite of sulfadiazine.
Shear NH; Spielberg SP
Can J Physiol Pharmacol; 1985 Nov; 63(11):1370-2. PubMed ID: 4075255
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant toxicity in vitro: possible role of arene oxides.
Spielberg SP; Gordon GB; Blake DA; Mellits ED; Bross DS
J Pharmacol Exp Ther; 1981 May; 217(2):386-9. PubMed ID: 7229980
[TBL] [Abstract][Full Text] [Related]
3. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
[TBL] [Abstract][Full Text] [Related]
4. Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism.
Spielberg SP; Gordon GB
J Clin Invest; 1981 Jan; 67(1):37-41. PubMed ID: 7451657
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.
Rieder MJ; Uetrecht J; Shear NH; Spielberg SP
J Pharmacol Exp Ther; 1988 Feb; 244(2):724-8. PubMed ID: 3346843
[TBL] [Abstract][Full Text] [Related]
6. Drug metabolite toxicity assessed in human lymphocytes with a purified, reconstituted cytochrome P-450 system.
Leeder JS; Cannon M; Nakhooda A; Spielberg SP
J Pharmacol Exp Ther; 1988 Jun; 245(3):956-62. PubMed ID: 3385648
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations.
Miller KJ; Anderholm DC; Ames MM
Biochem Pharmacol; 1986 May; 35(10):1737-42. PubMed ID: 3707603
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes.
Madden S; Woolf TF; Pool WF; Park BK
Biochem Pharmacol; 1993 Jul; 46(1):13-20. PubMed ID: 8347124
[TBL] [Abstract][Full Text] [Related]
9. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
10. An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes.
Tingle MD; Pirmohamed M; Templeton E; Wilson AS; Madden S; Kitteringham NR; Park BK
Biochem Pharmacol; 1993 Nov; 46(9):1529-38. PubMed ID: 8240407
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
Madan A; Parkinson A
Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
[TBL] [Abstract][Full Text] [Related]
12. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
Coleman MD; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of hydralazine by rat liver microsomes.
LaCagnin LB; Colby HD; Dalal NS; O'Donnell JP
Biochem Pharmacol; 1987 Aug; 36(16):2667-72. PubMed ID: 3038130
[TBL] [Abstract][Full Text] [Related]
14. Covalent binding of 14C- and 35S-labeled thiocarbamides in rat hepatic microsomes.
Decker CJ; Doerge DR
Biochem Pharmacol; 1992 Feb; 43(4):881-8. PubMed ID: 1371686
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
Masubuchi Y; Araki J; Narimatsu S; Suzuki T
Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
[TBL] [Abstract][Full Text] [Related]
16. Acetaminophen toxicity in human lymphocytes in vitro.
Spielberg SP
J Pharmacol Exp Ther; 1980 May; 213(2):395-8. PubMed ID: 7365697
[TBL] [Abstract][Full Text] [Related]
17. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
Orton TC; Lowery C
J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
[TBL] [Abstract][Full Text] [Related]
18. Characterization of covalent binding of N'-nitrosonornicotine in rat liver microsomes.
Hughes MF; Brock WJ; Marion LJ; Vore M
Carcinogenesis; 1986 Jan; 7(1):3-8. PubMed ID: 3510749
[TBL] [Abstract][Full Text] [Related]
19. Metabolism-dependent covalent binding of (S)-[5-3H]nicotine to liver and lung microsomal macromolecules.
Shigenaga MK; Trevor AJ; Castagnoli N
Drug Metab Dispos; 1988; 16(3):397-402. PubMed ID: 2900731
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man.
Mitchell MC; Schenker S; Speeg KV
J Clin Invest; 1984 Feb; 73(2):383-91. PubMed ID: 6142056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
